20 Prominent Biotechnology Firms in New York
20 Prominent Biotechnology Firms in New York
Biotechnology is a rapidly-evening sector bridging the gap between biology and technology. The companies operating in this industry are primarily tasked with utilizing biological systems to develop technologies and products that improve our lives. These are often in the form of medicinal innovations, agriculture enhancements, and environmental solutions. The New York biotech scene particularly thrives in medicinal innovation, playing host to big players and emerging startups alike. Their collective work promises to catapult healthcare to new heights in the future.
Top 20 biotechnology companies in New York
1. Pfizer
- Website: pfizer.com
- Headquarters: New York, New York, United States
- Founded: 1849
- Headcount: 10001+
- Latest funding type: Grant
Pfizer Inc. is a leading biopharmaceutical company that specializes in the research, development, production, and distribution of innovative medicines and vaccines. With a commitment to improving global health, Pfizer strives to discover breakthrough treatments for various diseases, including cancer, infectious diseases, and inflammation. The company has a strong focus on patient care and collaboration with healthcare professionals to provide effective therapies. Pfizer's dedication to scientific innovation, ethical leadership, and sustainability makes it a trusted industry leader.
2. Regeneron
- Website: regeneron.com
- Headquarters: Tarrytown, New York, United States
- Founded: 1988
- Headcount: 5001-10000
- Latest funding type: Post Ipo Equity
Regeneron Pharmaceuticals is a biopharmaceutical company that develops and manufactures biologic medicines. They are known for their commitment to scientific research and groundbreaking discoveries. Their goal is to improve human health through the development of innovative therapies.
3. Intra-Cellular Therapies
- Website: intracellulartherapies.com
- Headquarters: New York, New York, United States
- Founded: 2002
- Headcount: 501-1000
- Latest funding type: Post Ipo Equity
Intra-Cellular Therapies is a pharmaceutical company focused on developing innovative treatments for neuropsychiatric, neurologic, and other disorders. Their mission is to improve the lives of individuals with these conditions and reduce the burden on patients and caregivers.
4. Iavi
- Website: iavi.org
- Headquarters: New York, New York, United States
- Founded: 1996
- Headcount: 201-500
IAVI is an organization dedicated to researching and developing vaccines and antibodies for HIV, TB, emerging infectious diseases, and neglected diseases. They work towards disease prevention and treatment challenges, with a focus on global accessibility and public health solutions.
5. Stemline Therapeutics
- Website: stemline.com
- Headquarters: New York, New York, United States
- Founded: 2003
- Headcount: 51-200
Stemline Therapeutics, part of the Menarini Group, is a pharmaceutical company focused on developing innovative therapies in oncology. With a broad pipeline of transformative treatments, Stemline is committed to using scientific leadership to improve the lives of patients with cancer.
6. MindMed
- Website: mindmed.co
- Headquarters: New York, New York, United States
- Founded: 2019
- Headcount: 51-200
- Latest funding type: Post Ipo Equity
MindMed is a company focused on delivering novel treatments for a wide range of brain health disorders. They strive to harness the therapeutic potential of psychedelics and other novel compounds to address unmet patient needs in the fields of psychiatry, addiction, pain, and neurology.
7. Kallyope
- Website: kallyope.com
- Headquarters: New York, New York, United States
- Founded: 2015
- Headcount: 51-200
- Latest funding type: Series D
Kallyope is a New York-based biotech company that focuses on developing groundbreaking medicines by harnessing the gut-brain axis. Their Klarity™ Platform integrates leading technologies to discover and translate gut-brain biology, with a focus on metabolic conditions, gastrointestinal disease, and neurological disorders.
8. Emendo Biotherapeutics
- Website: emendobio.com
- Headquarters: New York, New York, United States
- Founded: 2015
- Headcount: 51-200
- Latest funding type: Series B
EmendoBio is a company that specializes in creating novel and elegant CRISPR solutions to make a positive and profound impact on human health.
9. Neurogene Inc.
- Website: neurogene.com
- Headquarters: New York, New York, United States
- Founded: 2018
- Headcount: 51-200
- Latest funding type: Series A
Neurogene is a biotech company focused on developing gene therapies for rare neurological diseases. They are dedicated to addressing the high unmet need in this field and aim to revolutionize medical treatment through innovation and scientific execution. With a strong sense of purpose, Neurogene aims to develop life-changing genetic medicines for individuals and families affected by devastating neurological conditions.
10. Massive Bio
- Website: massivebio.com
- Headquarters: New York, New York, United States
- Founded: 2014
- Headcount: 51-200
- Latest funding type: Series B
Massive Bio is an AI-driven platform connecting cancer patients and their oncologists to bio-pharmaceutical clinical trials that offer new, alternative, and targeted treatments to help create positive patient outcomes.
11. D. E. Shaw Research
- Website: deshawresearch.com
- Headquarters: New York, New York, United States
- Founded: 2002
- Headcount: 51-200
D.E. Shaw Research is a computational chemistry company specializing in the discovery and development of new therapeutics. They use cutting-edge technologies and computational methods to understand and manipulate biological molecules at the atomic level, with a focus on drug discovery. Their expertise lies in molecular dynamics simulations, machine learning, and supercomputers. D.E. Shaw Research aims to reshape the drug discovery process by identifying new strategies and elucidating molecular mechanisms.
12. Turnstone Biologics
- Website: turnstonebio.com
- Headquarters: New York, New York, United States
- Founded: 2015
- Headcount: 51-200
- Latest funding type: Series D
Turnstone Biologics is a company focused on developing innovative therapies for solid tumors. They specialize in selecting and manufacturing potent tumor-reactive T-cells to overcome the limitations of current therapies. Their approach involves capturing a diverse range of patient-specific tumor antigens to stimulate a robust T-cell response. Turnstone Biologics aims to revolutionize the treatment of solid tumors by shifting the paradigm and improving patient outcomes.
13. Neochromosome, Inc.
- Website: neochromosome.com
- Headquarters: New York, New York, United States
- Headcount: 11-50
Neochromosome is a company that offers DNA services and specializes in cell engineering, particularly with their NeoYeast product. They provide cutting-edge solutions for protein drug discovery and manufacturing science.
14. LEXEO Therapeutics
- Website: lexeotx.com
- Headquarters: New York, New York, United States
- Founded: 2018
- Headcount: 11-50
- Latest funding type: Series B
LEXEO is a gene therapy company that develops investigational therapies for rare monogenic diseases and diseases affecting prevalent patient populations. They utilize engineered adeno-associated viruses to transfer therapeutic genes to patients, targeting genetically defined cardiovascular and central nervous system diseases. LEXEO's therapies have potential in treating Friedreich's Ataxia, Alzheimer's, and other similar conditions.
15. OncoPrecision
- Website: oncoprecision.bio
- Headquarters: New York, New York, United States
- Founded: 2020
- Headcount: 11-50
- Latest funding type: Seed
OncoPrecision is a company specializing in Precision Oncology, offering innovative technologies and applications for the personalized treatment of cancer. Their platform combines biology and AI to replicate patients' diseases and unlock precise predictions of their response to various cancer therapies.
16. Ovid Therapeutics
- Website: ovidrx.com
- Headquarters: New York, New York, United States
- Founded: 2014
- Headcount: 11-50
- Latest funding type: Post Ipo Equity
Ovid Therapeutics is a pharmaceutical company focused on developing impactful medicines for rare neurological disorders. Their deep understanding of human genetics and cellular function enables them to translate discoveries into meaningful therapies for epilepsies and seizure-related disorders.
17. SyntekaBio Inc
- Website: syntekabio.com
- Headquarters: New York, New York, United States
- Founded: 2009
- Headcount: 11-50
- Latest funding type: Post Ipo Equity
Syntekabio is a company that offers innovative solutions in the field of biotechnology. They specialize in developing advanced genetic sequencing technologies and bioinformatics software. With their cutting-edge products, they aim to revolutionize the way genetic information is analyzed and utilized.
18. Volastra Therapeutics
- Website: volastratx.com
- Headquarters: New York, New York, United States
- Founded: 2019
- Headcount: 11-50
- Latest funding type: Series A
Volastratx.com is a company dedicated to finding a cure for cancer. They aim to identify and understand the drivers of cancer in order to develop effective treatments.
19. Cambrian BioPharma
- Website: cambrianbio.com
- Headquarters: New York, New York, United States
- Founded: 2019
- Headcount: 11-50
- Latest funding type: Series C
Cambrian Bio is a biotech company that is dedicated to building the medicines of the future. They focus on developing therapeutics to extend the period of good health and redefine healthcare in the 21st century.
20. OnCusp Therapeutics
- Website: oncusptx.com
- Headquarters: New York, New York, United States
- Founded: 2021
- Headcount: 11-50
OnCusp Therapeutics is a company focused on transforming cutting-edge research assets into clinically proven therapeutics for cancer patients worldwide.
Want to find more biotechnology companies?
If you want to find more companies that offer groundbreaking medical solutions and advanced therapeutic treatments you can do so with Inven. This list was built with Inven and there are hundreds of companies like these globally.
With Inven you'll also get to know the company's:
- Ownership: Which of these are private equity backed? Which are family-owned?
- Contact data: Who are the owners and CEO's? What are their emails and phone numbers?
- Financials: How do these companies perform financially? What are their revenues and profit margins?
...and a lot more!
